Back to Search Start Over

Rare predicted deleterious FEZF2 variants are associated with a neurodevelopmental phenotype.

Authors :
Garber, Alison
Weingarten, Lisa S.
Abreu, Nicolas J.
Elloumi, Houda Zghal
Haack, Tobias
Hildebrant, Clara
Martínez‐Gil, Núria
Mathews, Jennifer
Müller, Amelie Johanna
Valenzuela Palafoll, Irene
Steigerwald, Connolly
Chung, Wendy K.
Source :
American Journal of Medical Genetics. Part A; Jul2024, Vol. 194 Issue 7, p1-10, 10p
Publication Year :
2024

Abstract

FEZF2 encodes a transcription factor critical to neurodevelopment that regulates other neurodevelopment genes. Rare variants in FEZF2 have previously been suggested to play a role in autism, and cases of 3p14 microdeletions that include FEZF2 share a neurodevelopmental phenotype including mild dysmorphic features and intellectual disability. We identified seven heterozygous predicted deleterious variants in FEZF2 (three frameshifts, one recurrent missense in two independent cases, one nonsense, and one complete gene deletion) in unrelated individuals with neurodevelopmental disorders including developmental delay/intellectual disability, autism, and/or attention‐deficit/hyperactivity. Variants were confirmed to be de novo in five of seven cases and paternally inherited from an affected father in one. Predicted deleterious variants in FEZF2 may affect the expression of genes that are involved in fate choice pathways in developing neurons, and thus contribute to the neurodevelopmental phenotype. Future studies are needed to clarify the mechanism by which FEZF2 leads to this neurodevelopmental disorder. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
15524825
Volume :
194
Issue :
7
Database :
Complementary Index
Journal :
American Journal of Medical Genetics. Part A
Publication Type :
Academic Journal
Accession number :
177740909
Full Text :
https://doi.org/10.1002/ajmg.a.63578